In addition, compared with HD-MSC, CML-MSC over-expressed some immunomodulatory factors including TGFβ, IL6 and IL10, that could be involved in MDSC activation. This evidence concerns the gene TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive.